SPI

SPI handeln
18.684,24 PKT +101,75 PKT +0,55 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
17.04.19 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
17.04.19 Roche Neutral UBS AG
17.04.19 ABB (Asea Brown Boveri) Neutral UBS AG
17.04.19 Roche buy Goldman Sachs Group Inc.
17.04.19 Novartis buy Jefferies & Company Inc.
17.04.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
17.04.19 Swiss Re Sector Perform RBC Capital Markets
16.04.19 Novartis buy Kepler Cheuvreux
16.04.19 Swiss Re overweight JP Morgan Chase & Co.
12.04.19 Zurich Insurance Neutral JP Morgan Chase & Co.
12.04.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
12.04.19 ABB (Asea Brown Boveri) buy Deutsche Bank AG
12.04.19 Holcim overweight JP Morgan Chase & Co.
12.04.19 Holcim Neutral Goldman Sachs Group Inc.
11.04.19 Nestlé overweight Morgan Stanley
11.04.19 Givaudan Neutral UBS AG
11.04.19 Holcim Sell UBS AG
11.04.19 UBS buy Deutsche Bank AG
11.04.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
11.04.19 Roche buy Goldman Sachs Group Inc.
11.04.19 ams-OSRAM overweight Barclays Capital
10.04.19 Givaudan Hold Kepler Cheuvreux
10.04.19 Alcon Neutral UBS AG
10.04.19 Novartis Underweight Barclays Capital
10.04.19 Nestlé overweight Barclays Capital
10.04.19 Novartis Underweight Morgan Stanley
09.04.19 Givaudan Sell Goldman Sachs Group Inc.
09.04.19 UBS Neutral JP Morgan Chase & Co.
09.04.19 UBS overweight JP Morgan Chase & Co.
09.04.19 Givaudan Underperform Bernstein Research
09.04.19 Givaudan Sell Goldman Sachs Group Inc.
09.04.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
08.04.19 Holcim buy Deutsche Bank AG
08.04.19 UBS buy UBS AG
08.04.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
08.04.19 Novartis Underweight JP Morgan Chase & Co.
08.04.19 Swiss Re overweight JP Morgan Chase & Co.
08.04.19 Novartis Underweight Barclays Capital
05.04.19 Novartis Neutral Credit Suisse Group
05.04.19 UBS overweight Morgan Stanley